Patients & Caregivers
Contact Us
Français
Home
Overview
Major Accomplishments
Working at Merck
Search Jobs, Submit Resume, Log on
Career Choices
Students and recent Grads
Careers Questions
Partners
Company Overview
Community Relations
Frequently Asked Questions
VIOXX® Information Center
Terms and Conditions of Sales
Corporate News
Executive Speeches
Product News
Research & Development News
Media Contact
Newsroom
Corporate News
Photos
Executive Speeches
Product News
CANCIDAS
®
COSOPT
®
COZAAR
®
CRIXIVAN
®
EMEND
®
FOSAMAX
®
FOSAVANCE
®
GARDASIL
®
INTRON A
®
INVANZ
®
ISENTRESS
®
JANUMET
TM
JANUVIA
®
MAXALT
®
PEGETRON
®
PROPECIA
®
PROSCAR
®
ROTATEQ
®
SINEMET
®
SINGULAIR
®
VARIVAX
®
III
VASOTEC
®
VICTRELIS
TM
VIOXX
®
ZOCOR
®
ZOLINZA
®
ZOSTAVAX
TM
EZETROL
®
Research & Development News
Media Contact
INTRON A®
Press Releases
Jan 31, 2011
Meta-analysis of interferon alfa studies cited as “Notable Advance” in BEST OF 2010 REPORT BY AMERICAN SOCIETY OF CLINICAL ONCOLOGY - Improved survival in patients with deadliest form of skin cancer
Product Monograph / Prescribing Information / Product Information
Studies
Disease Fact Sheets
Product Fact Sheets
Photos
B-Roll
What's New
Gardasil
®
Approved To Help Prevent Anal Cancer In Women And Men
Contact
Media contacts
.
Printer friendly
This site is for residents of Canada. / This site was updated on October 26, 2011.
